miRNA | Expression | Target | Type of biomarker | Type of sample | References |
let-7 | Down | HMGA1; HMGA2; Ras; Myc | Proliferation | Y79 | [9] [19] |
let-7e | Down |
|
| Plasma | [17] |
let-7g | Up | NRAS; TGFBR1; IGF1R; MYCN; MAPK6; TP53 |
| Y79 | [15] |
miR-18a | Up |
| Proliferation; Apoptosis | Serum | [16] |
miR-20a | Up |
| Proliferation; Apoptosis | Serum | [16] |
miR-21 | Up | PTEN/Akt pathway | Proliferation; Migration; Invasion | Plasma | [17] |
miR-22 | Up | ESR1; BCL9L; ERBB3; SP1; SATB2; RAB5B; CAV3 |
| Y79 | [15] |
miR-31 | Down | STK40, PPP6C; DLL3 | Proliferation; apoptosis | Weri-Rb1, Y79 | [20] |
miR-34a | Up | MDMX; Sirtl; HMGB1; p53 | Tumor suppressor; proliferation | Y79 | [13] |
miR-129-1; 2 | Up | EF2; cell cycle | Tumorogenesis | Tissue human | [14] |
miR-198 | Up | EF2; cell cycle | Tumorogenesis | Tissue human | [14] |
miR-25-3p | Up |
| Cell proliferation, migration; invasion | Weri-Rb1, Y79, SO-RB50; tumor tissues | [14] |
miR-224-3p | Up | LATS2/Hippo-YAP axis | Proliferation; angiogenesis | RB cell lines (Y79) and tumor tissues | [21] |
miR-320 | Up/Down | EF2; cell cycle | Tumorogenesis | Tissue human; plasma | [14] [17] |
miR-373 | Up | EF2; cell cycle | Tumorogenesis | Tissue human | [15] |
miR-492 | Up | EF2; cell cycle | Tumorogenesis | Tissue human | [14] |
miR-494 | Up | EF2; cell cycle | Tumorogenesis | Tissue human | [14] |
miR-498 | Up | EF2; cell cycle | Tumorogenesis | Tissue human | [14] |
miR-503 | Up | EF2; cell cycle; CBX4; IGF1; M CPEB2; PIK3R1 | Tumorogenesis | Tissue human | [14] [15] |
miR-513-1; 2 | Up | EF2; cell cycle | Tumorogenesis | Tissue human | [19] |
miR-518c | Up | EF2; cell cycle | Tumorogenesis | Tissue human | [19] |
miR17-92 (OncomiR-1) | Up | p21CIP1; p57KIP2; EpCAM STAT3 | Proliferation; cell cycle; inhibit differentiation; angiogenesis | Y79; Tissue human | [18] [22] |